iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab
Clinical trial NCT03350126 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03350126
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-04
- Primary completion
- 2020-01-10
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.